Elsa receives a 200’000 Euro grant from Vinnova for building prediction algorithms

Elsa Science
Mar 28 · 1 min read

Rheumatoid arthritis (RA) affects about 5 million people in Europe and costs European society approximately 35 billion Euro per year (including societal costs, i.e. lost income etc). All ages are affected but disease frequency increase with age, meaning that the number of RA patients is increasing in Europe due to an ageing population. Patients with RA have decreased working ability and they often suffer from pain and comorbidities even if they are medicated. Only about 20% of patients get full remission. Together with Karolinska Institutet we are now trying to change this progression by building prediction algorithms of treatment effect in order to enable “tight control” as well as educating and supporting patients with lifestyle changes.

Early idea to be further developed
Elsa Science

Written by

Elsa helps patients with chronic disease live a better life.